Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ROX CONTROL HTN Study: A Prospective, Randomized, Open-Label, Multicenter Study to Evaluate the ROX Coupler in Patients With Resistant Hypertension

NCT01642498 is registered in ClinicalTrials.gov with ROX Medical, Inc. as lead sponsor.

NCT NCT01642498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01642498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ROX CONTROL HTN Study: A Prospective, Randomized, Open-Label, Multicenter Study to Evaluate the ROX Coupler in Patients With Resistant Hypertension
Lead sponsor
ROX Medical, Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 1, 2012
Completion date
June 30, 2018
Enrollment
100 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension